Cargando…
Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches
The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenoviruses (AdV) and especially adeno-associated viruses (AAV) a...
Autores principales: | Aledo-Serrano, Angel, Gil-Nagel, Antonio, Isla, Julian, Mingorance, Ana, Mendez-Hermida, Fernando, Hernandez-Alcoceba, Ruben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284696/ https://www.ncbi.nlm.nih.gov/pubmed/34271959 http://dx.doi.org/10.1186/s13023-021-01958-3 |
Ejemplares similares
-
Was that endoscopy necessary?
por: Navarro, Rubén Linares, et al.
Publicado: (2023) -
The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study
por: Aledo-Serrano, Ángel, et al.
Publicado: (2022) -
High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
por: Ricobaraza, Ana, et al.
Publicado: (2020) -
Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022) -
C(t) values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load
por: Dahdouh, Elias, et al.
Publicado: (2021)